• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
HIV / AIDS - Pipeline Review, Q4 2010 - Product Image

HIV / AIDS - Pipeline Review, Q4 2010

  • ID: 1464171
  • December 2010
  • 383 pages
  • Global Markets Direct

HIV / AIDS - Pipeline Review, Q4 2010

Summary

Global Markets Direct’s, “HIV and Aids Pipeline Review, Q4 2010”, provides an overview of the HIV and Aids therapeutic pipeline. This report provides information on the therapeutic development for HIV and Aids, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for HIV and Aids. “HIV and Aids-Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- A snapshot of the global therapeutic scenario for HIV and Aids.
- A review of the HIV and Aids products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
HIV / AIDS Overview
Therapeutics Development
An Overview of Pipeline Products for HIV / AIDS
HIV / AIDS Therapeutics under Development by Companies
HIV / AIDS Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Companies Involved in HIV / AIDS Therapeutics Development
Bristol-Myers Squibb Company
Johnson & Johnson
Boehringer Ingelheim GmbH
Abbott Laboratories
Vical Incorporated
Valeant Pharmaceuticals International
GlaxoSmithKline plc
Nektar Therapeutics
Antigenics, Inc.
Inovio Biomedical Corporation
Bavarian Nordic A/S
Endo Pharmaceuticals Holdings Inc.
Gilead Sciences, Inc.
Targeted Genetics Corporation
VIRxSYS Corporation
Merck & Co., Inc.
Lentigen Corporation
Myriad Genetics, Inc.
Sangamo BioSciences, Inc.
Generex Biotechnology Corporation
Nanotherapeutics, Inc.
Ambrilia Biopharma Inc.
Panacos Pharmaceuticals, Inc.
Biotron Limited
Aphios Corporation
Achillion Pharmaceuticals, Inc.
Dong-A Pharmaceutical Co., Ltd.
InterMune, Inc.
Japan Tobacco Inc.
Pfizer Inc.
Progenics Pharmaceuticals, Inc.
Avexa Limited
Koronis Pharmaceuticals, Inc.
Trimeris, Inc.
Astex Therapeutics Limited
Cyclacel Pharmaceuticals Inc.
Radboud University
Inhibitex, Inc.
GeoVax Labs, Inc.
Hemispherx Biopharma, Inc.
Celldex Therapeutics, Inc.
Enzo Biochem, Inc.
Ardea Biosciences, Inc.
Medivir AB
Bio-Bridge Science, Inc.
Mymetics Corporation
NanoViricides, Inc.
Nutra Pharma Corporation
Peregrine Pharmaceuticals, Inc.
Pharmasset, Inc
CytoGenix, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases
CytRx Corporation
Starpharma Holdings Limited
Samaritan Pharmaceuticals, Inc.
BioAlliance Pharma SA
Narhex Life Sciences Limited
Affitech A/S
French National Agency for Research on AIDS and Viral Hepatitis
Artec, Inc.
AplaGen GmbH
Neorphys
Actis Biologics, Inc
BioMAS Ltd.
ViroStatics, srl
Argos Therapeutics, Inc.
Cytheris SA
AiCuris GmbH & Co. KG
Viroblock S.A.
AlphaVax, Inc.
S-BIO Pte Ltd
ReProtect, Inc.
Sequoia Pharmaceuticals, Inc.
Rottapharm SpA
Xigen SA
Indus Biotech Private Limited
Presidio Pharmaceuticals, Inc.
Chimerix, Inc.
Theraclone Sciences, Inc.
Frontier Biotechnologies, Inc.
Viral Genetics, Inc.
Concert Pharmaceuticals, Inc.
CytoDyn, Inc.
Oncolys BioPharma Inc.
PepTcell Limited
Arisyn Therapeutics Inc.
Tobira Therapeutics, Inc.
Genetic Immunity, LLC
Bionor Immuno AS
Virax Holdings Limited
TNI Pharmaceuticals, Inc.
GenPhar, Inc.
Pharis Biotec GmbH
FemmePharma Global Healthcare, Inc.
Amazon BioTech
The National Institute of Allergy and Infectious Diseases
Euroscreen Products S.A
ImQuest Pharmaceuticals, Inc.
International AIDS Vaccine Initiative
VIRIOM Ltd.
CONRAD
ViiV Healthcare
RFS Pharma, LLC
Helix Therapeutics LLC
ImQuest Life Sciences
Du Pont de Nemours International SA
Universities/Institutes Involved in HIV / AIDS Therapeutics Development
HIV / AIDS Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Companies
1349572 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ampligen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cobicistat - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Elvitegravir_ - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Kaletra + Combivir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + Stavudine + Lamivudin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PRO 2000/5 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
QS-21 Stimulon Adjuvant - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Quad - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir + Kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SP-01A - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TMC278 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + TMC 278 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VGV-1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Viramune + Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Late Stage Drug Profiles – Universities/Institutes
(Abacavir + Lamivudine) + Atazanavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
(Lopinavir/Ritonavir) + Nucleoside Reverse Transcriptase Inhibitors + PEG-IFNa 2a + Ribavirin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Didanosine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Didanosine + Lopinavir/Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Efavirenz + Lamivudine + Lopinavir + Ritonavir + Nelfinavir + Nevirapine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir + Lamivudine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir sulfate + Didanosine + Efavirenz + Lamivudine + Lopinavir/Ritonavir + Nevirapine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Abacavir/Lamivudine + Zidovudine + Nevirapine/Efavirenz/Nelfinavir/Lopinavir-Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Acyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Acyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Acyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Aldesleukin + ART - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Aluvia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Aluvia + Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ALVAC-HIV + AIDSVAX B/B - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Anti-HIV Immune Serum Globulin (Human) + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Anti-HIV Immune Serum Globulin (Human) + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
atazanavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Atazanavir + Didanosine + Efavirenz + Emtricitabine/Tenofovir disoproxil fumarate + Lamivudine + Lopinavir/Ritonavir + Nevirapine + Stavudine + Tenofovir disoproxil fumarate + Zidovudine/Lamivudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Atripla - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Buprenorphine + Naloxone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
chloroquine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Chloroquine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cidofovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cidofovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
clarithromycin + ethambutol + clofazimine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
clarithromycin + ethambutol + rifabutin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Darunavir + Ritonavir + Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Darunavir + Ritonavir_ - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Didanosine + Abacavir + kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Didanosine + Lamivudine + Nevirapine + 2EHRZ3/4RH3 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Didanosine + Zalcitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz + Lamivudine + Tenofovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz + Lamivudine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz + Lamivudine + Zidovudine + Indinavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Efavirenz + Stavudine + Lamivudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine + Tenofovir Disoproxil Fumarate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine + Tenofovir Disoproxil Fumarate + Lopinavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine + Tenofovir Disoproxil Fumarate + Lopinavir + Ritonavir + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine + Tenofovir Disoproxil Fumarate_ - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine/Tenofovir + Darunavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Emtricitabine/Tenofovir + Lopinavir/Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Enfuvirtide + Raltegravir + Darunavir + Tipranavir + Etravirine + Maraviroc - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Engerix-B - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Erythromycin + Nevirapine + Ampicillin sodium + Metronidazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Etravirine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Fuzeon + Truvada + Kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GPO-VIR S + GPO-VIR Z - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GPO-VIR Z - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HAART + Isentress - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HAART + Isentress + Celsentri - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Highly Active Antiretroviral Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Indinavir + Ritonavir + Abacavir + Didanosine + Proleukin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Indinavir sulfate + Lamivudine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Intelence - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Interleukin-2 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Intravenous Gamma Globulin + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Isentress + Celsentri + Truvada + Kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Isoniazid + Cotrimoxazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Kaletra + Lamivudine + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Kivexa - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lamivudine + Zidovudine + Nelfinavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lamivudine + Zidovudine + Nelfinavir + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Levocarnitine + Adefovir dipivoxil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lexiva + Norvir + Epzicom - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lopinavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
lopinavir + ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Methadone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
methadone + buprenorphine-naloxone (Suboxone) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nelfinavir + Lamivudine + Zidovudine + Indinavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + AZT - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + HIV Immune Globulin Solution - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + Lopinavir + Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Nevirapine + Rifampicin + Ethambutol + Isoniazid + Pyrazinamid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pegasys + Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pegylated interferon alfa-2a + Ribavirin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pentamidine + Dapsone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Prednisone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Prevenar + Pneumo23 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Anti-HIV Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Antiretroviral Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Paracetamol + Ibuprofen + Metoclopramide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Paracetamol + Ibuprofen + Metoclopramide + Codeine Phosphate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Paracetamol + Ibuprofen + Ondansetron - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proleukin + Paracetamol + Ibuprofen + Ondansetron + Codeine Phosphate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir + Maraviroc + Emtricitabine/Tenofovir + Lopinavir/Ritonavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir + Maraviroc + Tenofovir + Emtricitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Raltegravir + Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Remune + ALVAC(2)120(B,MN)GNP (vCP1452) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Reyataz + Isentress - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ribavirin + Interferon Alfa-2a - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ritonavir + Atazanavir + Epzicom - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ritonavir + saquinavir + efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Saquinavir/Ritonavir + Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + Lamivudine + Abacavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stavudine + lamivudine + zidovudine + didanosine + zalcitabine + nevirapine (NVP) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Sustiva + Epzicom - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Sustiva + Kivexa - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tenofovir + Emtricitabine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
tenofovir disoproxil fumarate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tenofovir Disoproxil Fumarate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Tenofovir/Emtricitabine + Efavirenz + Maraviroc + Raltegravir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Trimetrexate Glucuronate + Leucovorin Calcium - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Truvada + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Valacyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Valacyclovir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Valacyclovir Hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Valsartan - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Viread - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Viread + Aluvia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zalcitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Immunoglobulin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Lamivudine + Abacavir - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Lamivudine + Efavirenz - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Lamivudine + Kaletra - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Lamivudine + Nevirapine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Zalcitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zidovudine + Zalcitabine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ziodovudine + Alpha Interferon - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Zovirax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Discontinued Products
HIV / AIDS - Featured News
Nov 30, 2010: Argos Initiates Dosing Of Patients In Phase IIb HIV Clinical Trial Of Arcelis
Nov 29, 2010: GeoVax Labs' Strategy Supported By Encouraging Results Of European Therapeutic HIV/AIDS Vaccine Trial
Nov 23, 2010: Idenix Receives $20 Million Milestone Payment From ViiV Healthcare For Initiation Of Phase IIb Trial Of '761
Nov 18, 2010: Bionor Pharma's Vacc-4x Shows Statictically Significant Reduction In Viral Load In Phase IIb HIV Study
Nov 17, 2010: Inovio Pharmaceuticals' HIV DNA Vaccine Achieves Strong T-Cell Immune Responses In Phase I Human Trial
Nov 12, 2010: Inovio Pharmaceuticals To Present HIV Study Update At HVTN Conference
Nov 11, 2010: Theratechnologies Receives FDA Approval For EGRIFTA For Reduction Of Excess Abdominal Fat In HIV-Infected Patients With Lipodystrophy
Nov 08, 2010: Cytheris' ORVACS Phase II Clinical Study Combines Immunomodulatory Intervention And Antiretroviral Intensification To Attack Viral Reservoir Of HIV Patients
Oct 28, 2010: Sequoia Pharmaceuticals Presents In vitro and First-in-human Data Supporting Further Development of SPI-256, A Investigational Protease Inhibitor
Oct 21, 2010: Shionogi-ViiV Initiates Phase III Clinical Program For Investigational Once-Daily HIV Integrase Inhibitor
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos